Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses / Brodowicz T., Spanik S. ... [et al.]. Onkológia Roč. 10, č. 6 (2015), s. 402-403